Production

Pharma

Dispensaries

Investors

Sales and Operations

Consumer

Events and Networking

Politics and Law

Production

Pharma

Dispensaries

Investors

Sales and Operations

Consumer

Events and Networking

Politics and Law

Featured Articles

Featured Articles

Congressional Memo Touts Marijuana Momentum In 2021 And Lays Out 2022 Reform Priorities

Congressional Memo Touts Marijuana Momentum In 2021 And Lays Out 2022 Reform Priorities

With several new states having legalized marijuana in 2021—in addition to some modest congressional developments—reform advocates put some wins on the board this year. Now a congressional memo is laying out priorities to build upon those successes for 2022. Reps. Earl Blumenauer (D-OR) and Barbara Lee (D-CA), longstanding champions of reform, released the memo on behalf of the Congressional Cannabis Caucus that they co-chair. It lists the numerous pieces of marijuana legislation that have been filed this on Capitol Hill this session, including some that did advance, and then explains what to watch for next year. While the lawmakers’ memo—which was shared exclusively with Marijuana Moment ahead of its release—highlights momentum that has developed behind cannabis reform in the House this year, it also notes that the Senate still has a lot of work to do. In the meantime, arguably the most consequential reforms of 2021 did not take place in Congress. Instead, as the new report acknowledges, it was the record number of states that legalized marijuana for adult use, as well as Alabama legalizing medical cannabis.

Kyle Jaeger, Marijuana Moment, 12/15/2021 19:00:00

Open article: https://www.marijuanamoment.net/congressional-memo-touts-marijuana-momentum-in-2021-and-lays-out-2022-reform-priorities/

read more
Baltimore: City Officials Move to Abolish Pre-Employment Drug Screens for Many Public Employees

Baltimore: City Officials Move to Abolish Pre-Employment Drug Screens for Many Public Employees

City officials approved municipal provisions this week suspending pre-employment drug screenings for public employees in non-safety sensitive positions. The policy change — which took immediate effect — was campaigned for by Baltimore’s mayor, Brandon M. Scott, who said: “[O]utdated and costly pre-employment drug and alcohol screenings only served to block qualified and passionate residents from obtaining employment with the City. … I am grateful that we are making this change now so that we can continue to improve local government operations and better serve the people of Baltimore.” According to reporting in The Baltimore Sun, “Pre-employment drug testing still [will] apply for so-called positions of trust, which includes jobs responsible for children, the safety of others, money or sensitive materials. Hires for senior city staff, such as department and agency heads, also would be subject to such testing.” The new policy is known as Administrative Manual Policy 205-8.

NORML, 12/15/2021 19:00:00

Open article: https://norml.org/blog/2021/12/16/baltimore-city-officials-move-to-abolish-pre-employment-drug-screens-for-many-public-employees/

read more
German Company in Talks With Afghanistan On Cannabis Cultivation

German Company in Talks With Afghanistan On Cannabis Cultivation

It all began with a Nov. 24 tweet (in English) from the Ministry of Interior Affairs of the Taliban’s “Islamic Emirate of Afghanistan,” declared after the militant group seized control of the country in August. It stated that the deputy minister for counter-narcotics “met with a representative” of a corporation called Cpharm, which is to “invest $450 million in setting up a hashish-processing company in Afghanistan.” The tweet stated that “medicines and creams” are to be manufactured at the facility (indicating that the word “hashish” was being used as an imprecise stand-in for cannabis). It added: “The project will be officially launched soon and hundreds of people will get job opportunities on the project.” That same day, a report by Kabul-based Pajhwok Afghan News quoted an Interior Ministry representative, Qari Saeed Khosti, making the same announcement. Regarding the outlawed status of cannabis in the country, Khosti said: “It is grown nationwide and we want to set a legal framework for sowing this illicit crop.” This report initially identified Cpharm as an Australian firm. This was later corrected, and it was changed to German. Khosti made the correction on Twitter, saying “Our talks were not with…an Australian company, but a German company.” The confusion seems to be due to the fact that the Australian Cpharm is the first to readily pop up on Google. But Khosti’s tweeted correction only went out in Pashto—not in English.

Cannabis Now, Cannabis Now, 12/17/2021 01:23:00

Open article: https://cannabisnow.com/german-company-in-talks-with-afghanistan-about-cannabis-cultivation/

read more
Bill to expand medical marijuana program passes Ohio Senate

Bill to expand medical marijuana program passes Ohio Senate

More Ohio dispensaries could sell medical marijuana, cultivators could grow more of it, and more conditions would qualify for using it under legislation passed Wednesday by the Republican-led state Senate. The measure also calls for regulation of medical marijuana dispensaries to move from the pharmacy board to a new Division of Marijuana Control in the Commerce Department. The legislation now moves to the state House. Republican Rep. Steve Huffman, the Tipp City physician who proposed the changes, said they’re aimed at improving the program developed since Ohio legalized medical marijuana in 2016. The legislation outlines a goal of one dispensary for every 1,000 of the first 300,000 registered patients, then adding more dispensaries as needed. The list of conditions qualifying for treatment with marijuana would expand to include terminal illness, Autism spectrum disorder, chronic muscle spasms, and opioid use disorder.

Mmp News Author, Medical Marijuana Program Connection, 12/15/2021 23:58:00

Open article: https://mmpconnect.com/bill-to-expand-medical-marijuana-program-passes-ohio-senate/

read more
Pot producer Canopy to sell German pharma unit C3 on COVID-19 hit

Pot producer Canopy to sell German pharma unit C3 on COVID-19 hit

 Canadian pot producer Canopy Growth Corp (WEED.TO), said on Wednesday it would sell its German pharmaceuticals unit, C3 Cannabinoid Compound Co GmbH, to a local firm as revenue took a hit due to pandemic-related restrictions in the country. Shares of Canopy were down 3.4% at C$8.85 in afternoon trading.The Ontario-based company said it would get an upfront payment of about C$115.5 million ($89.51 million) from German pharmaceutical firm Dermapharm Holding SE (DMPG.DE) once the deal closes in January, and up to C$61.4 million in a milestone-based payment. That is lower than the C$342.9 million Canopy paid in 2019 to buy C3, which it had often described as “transformational” to its business. Recent COVID-19 lockdown measures in Germany due to soaring virus cases restricted people’s ability to visit doctors and pharmacies, and dented C3’s revenue in the past few quarters. Sales in the unit fell 13% to C$11.9 million, according to Canopy’s second-quarter earnings report

Cannabis Business Executive – Cannabis and Marijuana industry news, 12/16/2021 08:24:00

Open article: https://www.cannabisbusinessexecutive.com/2021/12/german-pharmaceutical-firm-enters-cannabis-space-with-purchase-of-canopy-growth-european-asset/

read more
Virginia General Assembly panel votes to recommend speeding up retail marijuana sales to 2023

Virginia General Assembly panel votes to recommend speeding up retail marijuana sales to 2023

The General Assembly’s Cannabis Oversight Commission has agreed to recommend that Virginia speed up the timeline for retail sales of recreational marijuana to 2023. Under a Democratic-controlled state legislature, Virginia legalized simple possession and limited home cultivation for adults earlier this year. However, retail sales were delayed until 2024, with lawmakers including a reenactment clause to the bill requiring that a second vote be held during the 2022 legislative session to move forward with the legal market. During a meeting on Thursday, members of the Cannabis Oversight Commission raised the possibility of accelerating legal sales to July 1, 2022, with the state’s Board of Pharmacy overseeing the market. Staff helping the commission informed members that the Cannabis Control Authority, the regulatory agency set up under the legislation, would need until at least 2023 to set regulations for the legal market.

Mmp News Author, Medical Marijuana Program Connection, 12/16/2021 21:42:00

Open article: https://mmpconnect.com/virginia-general-assembly-panel-votes-to-recommend-speeding-up-retail-marijuana-sales-to-2023/

read more

Join Our Mailing List

Older Posts

All Categories

Production

Consumer

Pharma

Events and Networking

Dispensaries

Politics and Law

Sales and Operations

Investors

View all categories

The Indica Perspective

Always the latest news you need.

Indica News brings you all the latest information from the cannabis world. Sign up today for the latest news.

Advertisement

Indica News

(833) 769-9333

info@indica.news

}

Monday - Friday: 8:00 AM - 5:00 PM

Follow Us

Indica News

(833) 450-9333

info@indica.news

}

Monday - Friday: 8:00 AM - 5:00 PM

Follow Us

Indica News

(833) 450-9333

info@indica.news

}

Monday - Friday: 8:00 AM - 5:00 PM